| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.0M | -30.6% |
| Cost of Revenue | $10.7M | -26.4% |
| Gross Profit | $1.3M | -52.8% |
| R&D Expense | $10.8M | +9.1% |
| SG&A Expense | $29.5M | +80.1% |
| Operating Income | -$47.5M | -584.7% |
| Interest Expense | $8.1M | +119.6% |
| Pre-tax Income | -$144.9M | -201.7% |
| Net Income | -$144.9M | -2577.6% |
| EPS (Basic) | -$16.38 | -128.8% |
| EPS (Diluted) | -$16.38 | -128.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.1M | — |
| Accounts Receivable | $2.6M | -9.8% |
| Inventory | $2.6M | +193.3% |
| Current Assets | $13.3M | — |
| Total Assets | $20.6M | -91.1% |
| Current Liabilities | $44.4M | +553.4% |
| Long-term Debt | $21.6M | +90.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.8M | -2095.0% |
| Capital Expenditures | $34K | -94.5% |
| Investing Cash Flow | -$34K | +94.5% |
| Financing Cash Flow | $33.1M | +6167.3% |
| Free Cash Flow | -$28.8M | -1390.7% |
| Total Liabilities |
| $46.6M |
| +68.9% |
| Stockholders' Equity | -$26.0M | +4.8% |